INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 31 December 2009
Total Net Assets |
£96.6m |
NAV per share |
154.4p |
Share Price |
126.0p |
Total value of unquoted investments |
£21.0m |
Total number of portfolio companies |
61 |
Cash |
2% |
Cash committed and reserved to unquoted investments |
14% |
Portfolio companies with < 1 year of cash |
12% |
Top Ten Holdings
Company Name |
% NAV |
Market Value |
Micromet |
9.7 |
9,334,405 |
Celgene |
6.7 |
6,460,871 |
Amgen |
5.8 |
5,579,657 |
Gilead Sciences |
4.3 |
4,136,675 |
Alexion Pharmaceuticals |
3.7 |
3,574,864 |
Genzyme |
3.4 |
3,270,469 |
Wright Medical |
3.2 |
3,096,028 |
EUSA Pharma |
3.1 |
2,960,028 |
Oxagen |
3.0 |
2,909,479 |
Insulet |
2.8 |
2,666,310 |
|
----------- |
-------------- |
Total |
45.7 |
43,988,786 |
Geographical Allocation |
% |
United States |
83 |
Europe |
13 |
Cash |
2 |
Australia |
2 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
76 |
Unquoted |
22 |
Cash |
2 |
|
----------- |
|
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
25 JANUARY 2010